Document is current
Any future updates will be listed below
-
Authors
,
,
Baxter, Sally L. http://orcid.org/0000-0002-5271-7690
de Sa, Virginia R. http://orcid.org/0000-0002-0989-3576
Ferryman, Kadija
Jain, Prachee
Lee, Cecilia S. http://orcid.org/0000-0003-1994-7213
Li-Pook-Than, Jennifer
Liu, T. Y. Alvin
Owen, Julia P.
Patel, Bhavesh http://orcid.org/0000-0002-0307-262X
Yu, Qilu http://orcid.org/0000-0003-2641-3535
Zangwill, Linda M.
,
Bahmani, Amir http://orcid.org/0000-0003-4533-9334
Chute, Christopher G. http://orcid.org/0000-0001-5437-2545
Edberg, Jeffrey C.
Hurst, Samantha http://orcid.org/0000-0001-9843-2845
Ishikawa, Hiroshi http://orcid.org/0000-0001-6310-5748
Lee, Aaron Y. http://orcid.org/0000-0002-7452-1648
McGwin, Gerald
McWeeney, Shannon http://orcid.org/0000-0001-8333-6607
Nebeker, Camille http://orcid.org/0000-0001-6819-1796
Owsley, Cynthia
Singer, Sara J.
,
Adib, Riddhiman
Adibuzzaman, Mohammad
Alavi, Arash http://orcid.org/0000-0002-7245-6889
Ashley, Catherine http://orcid.org/0009-0001-6325-3211
Baer, Adrienne
Benton, Erik http://orcid.org/0000-0001-5682-6133
Blazes, Marian
Cohen, Aaron
Cordier, Benjamin
Crist, Katie
Cuddy, Colleen
Gasimova, Aydan
Gim, Nayoon http://orcid.org/0000-0001-6169-7452
Hong, Stephanie http://orcid.org/0000-0002-0795-1293
Kim, Trina
Lin, Wei-Chun http://orcid.org/0000-0002-2226-4619
Mitchell, Jessica
Ngadisastra, Caitlyn
Patronilo, Victoria http://orcid.org/0000-0002-3504-6514
Shaffer, Jamie http://orcid.org/0000-0003-4045-7665
Soundarajan, Sanjay http://orcid.org/0000-0003-2829-8032
Zhao, Kevin http://orcid.org/0009-0004-4573-9412
,
Drolet, Caroline http://orcid.org/0000-0001-6343-2140
Lucero, Abigail http://orcid.org/0000-0003-2287-4190
Matthies, Dawn
Pittock, Hanna http://orcid.org/0009-0003-4909-6058
Watkins, Kate
York, Brittany
,
Amankwa, Charles E.
Bangudi, Monique
Haboudal, Nada http://orcid.org/0009-0004-0570-0185
Hallaj, Shahin http://orcid.org/0000-0002-9541-1915
Heinke, Anna http://orcid.org/0000-0002-7115-8767
Huang, Lingling http://orcid.org/0000-0002-8305-1035
Kalaw, Fritz Gerald P. http://orcid.org/0000-0002-3940-2272
Karsolia, Apoorva
Khazaei, Hadi http://orcid.org/0000-0002-8938-4412
Mohammed, Muna http://orcid.org/0000-0002-2129-6483
Simpkins, Kyongmi
,
Wang, Xujing
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (OT2OD032644, P30 DK035816, OT2OD032644, OT2OD032644, OT2OD032644, P30 DK035816, OT2OD032644, OT2OD032644, OT2OD032644, OT2OD032644, OT2OD032644, OT2OD032644, OT2OD032644, OT2OD032644, OT2OD032644, OT2OD032644, OT2OD032644, OT2OD032644)
- License Information
-
More Information
Article History
First Online: 8 November 2024
Competing interests
: S.B.: funding — NIH, University of California Office of the President, Research to Prevent Blindness; consultant — Topcon; equipment — Optomed. V.R.d.S.: funding — NSF, UCSD Social Sciences, Sanford Institute for Empathy and Compassion (Center for Empathy and Technology), Intel, Mathworks, UCSD instructional improvement grant, equipment funding from Adobe and NVIDIA, Kavli Institute for Brain and Mind, IBM, past funding from Sony; member — Cognitive Science Society Governing Board. K.F.: member — Institutional Review Board for the All of Us Research Program, Digital Ethics Advisory Panel for Merck KGaA (Merck Germany). C.S.L.: funding — NIH, Alzheimer’s Disease Drug Discovery Foundation, Gates Ventures, Research to Prevent Blindness. T.Y.A.L.: funding — Research to Prevent Blindness, Dr. H. James and Carole Free Career Development Award. B.P.: funding — NIH. L.M.Z: funding — NEI, NIH, The Glaucoma Foundation, Heidelberg Engineering, DRCR Retina Network/JAEB Center for Health Research, The Krupp Foundation; receipt of equipment, materials, software — Optomed, ICare, Topcon, Heidelberg Engineering, Carl Zeiss Meditec, Optovue/Visionix; consultant — Abbvie, Topcon Medical Systems; co-founder, inventor, board member, equity holder — AISight Health Inc. S.H.: funding — NIH, NIH/NARCH, RWJF, UCSD Herbert Wertheim School of Public Health. H.I.: funding — NIH; founder, stock holder — Gobiquity, Inc. A.Y.L.: funding — Santen, Topcon, Carl Zeiss Meditec, Regeneron, Amazon, Meta, Research to Prevent Blindness; personal fees — Genentech, Sanofi, US FDA, Johnson and Johnson, Boehringer Ingelheim, Gyroscope; non-financial support — iCareWorld, Optomed, Heidelberg, Microsoft. S.M.: Funding — NIH, Edward P. Evans Foundation, OHSU Knight Cancer Institute; receipt of in-kind contribution — Nike. C.N.: funding — NIH, NSF, PCORI. C.O.: consultant — Johnson and Johnson. L.H.: funding — NIH Grant UL1TR001442; consultant — Bristol Myers Squibb. The remaining authors declare no competing interests.
